Biology

Defining blood biomarkers to modify the diagnostic pathway of dementia

Clinical development of novel pharmacological treatments for Alzheimer’s disease

New approaches for developing disease modifying therapies in Alzheimer’s disease

Combination therapy for Alzheimer’s disease

Potential new symptomatic drugs for Alzheimer’s disease

Disease-modifying therapy for dementia: Challenges with early detection at pre-dementia stage

Ethical considerations of biomarker use in prodromal Alzheimer’s disease

The landscape of biomarkers for the management of Alzheimer’s disease

Task force from Geneva: Roadmap for biomarker validation in Alzheimer’s disease

Current approaches for the management of Alzheimer’s disease

Prevention strategies for Alzheimer’s disease

Imaging of Alzheimer’s disease